MagicTouch: Sirolimus Drug Coated Balloon Catheter
MagicTouch SCB - Concept Medical - Developing technologies for drug delivery with a strong emphasis on intellectual property.

Novel, First of its kind Sirolimus drug coated balloon catheter for the treatment coronary artery disease

MagicTouch is intended for in-stent restenosis, small vessels, bifurcation lesions and de-novo lesions

Sirolimus Coated

Balloon Catheter

MagicTouch SCB

Assuring Safety by Delivering Sirolimus

  • TECHNOLOGY - MagicTouch SCB

    TECHNOLOGY

    An innovative proprietary Nanolute technology providing better bioavailability of SIROLIMUS

  • COATING - MagicTouch SCB

    COATING

    Unique coating technology leads to 100% balloon surface coating

  • DRUG - MagicTouch SCB

    DRUG

    Sirolimus: A drug with proven safety profile

  • CARRIER - MagicTouch SCB

    CARRIER

    A biocompatible phospholipid drug carrier improving the adhesion property of Sirolimus

Nanolute Technology

NANOLUTE TECHNOLOGY is designed to improve the lipophilicity and bioavailability of Sirolimus

  • Phospholipid is a drug carrier with two lipophilic tails and one hydrophilic head.
  • Sirolimus is encapsulated in phospholipid with proprietary Nanolute technology.

Know More

Unique Coating Technology

Drug carrier along with drug is coated on the unfolded balloon to achieve 100% coating on balloon surface
Unique and proprietary refolding mechanism facilitates better crossing profile

TECHNICAL SPECIFICATION

DRUG/EXCIPIENT
Drug Sirolimus
Drug Dose 1.27µg/mm²
Drug Carrier Phospholipid Based Excipient
Balloon
Balloon Material Polyamide
Catheter design Rapid Exchange(RX) Design
Delivery system
Shaft Diameter – Proximal 1.7 F
Shaft Diameter – Distal 2.5 F
Usable Catheter Length 140 cm
Tip Profile 0.016”
Nominal Pressure 6 bar
Rated Burst Pressure 16 bar (14 bar for 4.00/ 25 to 40 mm)
Guiding Catheter Compatibility 5F
Guidewire Compatibility 0.014” maximum recommended

ORDERING INFORMATION

Diameter/Length 10 mm 15 mm 20 mm 25 mm 30 mm 35 mm 40 mm
1.50 mm CMT15010 CMT15015 CMT15020 CMT15025 CMT15030 CMT15035 CMT15040
2.00 mm CMT20010 CMT20015 CMT20020 CMT20025 CMT20030 CMT20035 CMT20040
2.25 mm CMT22510 CMT22515 CMT22520 CMT22525 CMT22530 CMT22535 CMT22540
2.50 mm CMT25010 CMT25015 CMT25020 CMT25025 CMT25030 CMT25035 CMT25040
2.75 mm CMT27510 CMT27515 CMT27520 CMT27525 CMT27530 CMT27535 CMT27540
3.00 mm CMT30010 CMT30015 CMT30020 CMT30025 CMT30030 CMT30035 CMT30040
3.50 mm CMT35010 CMT35015 CMT35020 CMT35025 CMT35030 CMT35035 CMT35040
4.00 mm CMT40010 CMT40015 CMT40020 CMT40025 CMT40030 CMT40035 CMT40040

 

For Concept Medical BV

Diameter/Length 10 mm 15 mm 20 mm 25 mm 30 mm 35 mm 40 mm
1.50 mm CMN15010 CMN15015 CMN15020 CMN15025 CMN15030 CMN15035 CMN15040
2.00 mm CMN20010 CMN20015 CMN20020 CMN20025 CMN20030 CMN20035 CMN20040
2.25 mm CMN22510 CMN22515 CMN22520 CMN22525 CMN22530 CMN22535 CMN22540
2.50 mm CMN25010 CMN25015 CMN25020 CMN25025 CMN25030 CMN25035 CMN25040
2.75 mm CMN27510 CMN27515 CMN27520 CMN27525 CMN27530 CMN27535 CMN27540
3.00 mm CMN30010 CMN30015 CMN30020 CMN30025 CMN30030 CMN30035 CMN30040
3.50 mm CMN35010 CMN35015 CMN35020 CMN35025 CMN35030 CMN35035 CMN35040
4.00 mm CMN40010 CMN40015 CMN40020 CMN40025 CMN40030 CMN40035 CMN40040

 

Talk to a representative
Fill out a quick form and our representatives will be in touch.


MagicTouch SCB

Clinical Programs

Sr. No Study Name Type of Study Target Patients Country Clinical Trials Identifier
Sr. No:  1 Study Name:   EASTBOURNE Type of Study:  Prospective, Multi-Center, spontaneous clinical registry Target Patients:  2123 Country:  India, Malaysia, Greece, Italy, Spain, Ireland Clinical Trials Identifier:  https://clinicaltrials.gov/ct2/show/NCT03085823
Sr. No:  2 Study Name:   Nanolute Type of Study:  Prospective, Multi-Center, Real world Target Patients:  450 Country:  India Clinical Trials Identifier:  
Sr. No:  3 Study Name:   Transform I Type of Study:  Prospective, randomized , Multi-Center study Target Patients:  114 Country:  Italy, UK, Ireland Clinical Trials Identifier:  https://clinicaltrials.gov/ct2/show/NCT03913832
Sr. No:  4 Study Name:   Brazil-FIM Type of Study:  Prospective, Multi-Center, Non-randomised, First-In-Man Target Patients:  30 Country:  Brazil Clinical Trials Identifier:  https://clinicaltrials.gov/ct2/show/NCT02400632
Sr. No:  5 Study Name:   FASICO Type of Study:  Prospective, Single arm, Single-center Target Patients:  32 Country:  Italy Clinical Trials Identifier:  
Sr. No:  6 Study Name:   UK-SEB REGISTRY Type of Study:  Spontaneous, Clinical, Observational trial Target Patients:  500 Country:  UK Clinical Trials Identifier:  
Sr. No:  7 Study Name:   Nanolute CIMS Type of Study:   Target Patients:  131 Country:  India Clinical Trials Identifier:  
Sr. No:  8 Study Name:   SELFIE Type of Study:   Target Patients:  62 Country:  Italy Clinical Trials Identifier:  
Sr. No:  9 Study Name:   JAPAN - ISR Type of Study:   Target Patients:  50 Country:  Japan Clinical Trials Identifier:  
Sr. No:  10 Study Name:   Japan – SV Type of Study:   Target Patients:  170 Country:  Japan Clinical Trials Identifier:  
Sr. No:  11 Study Name:   UK-SEB REGISTRY 2 Type of Study:   Target Patients:  1000 Country:  UK Clinical Trials Identifier:  
Sr. No:  12 Study Name:   TRANFORM II Type of Study:   Target Patients:  1325 Country:  Italy, UK, Poland, Spain, Portugal, The Netherlands Clinical Trials Identifier:  https://clinicaltrials.gov/ct2/show/NCT04893291
Sr. No:  13 Study Name:   PICCOLETO III (RCT) Type of Study:   Target Patients:  450 Country:  Italy, UK Clinical Trials Identifier:  
Sr. No:  14 Study Name:   GINGER Type of Study:   Target Patients:  100 Country:   Clinical Trials Identifier:  
Sr. No:  15 Study Name:   TITAN Type of Study:   Target Patients:  130 Country:   Clinical Trials Identifier:  
Sr. No:  16 Study Name:   The MAGICAL Registry (US FDA) Type of Study:   Target Patients:  300 Country:   Clinical Trials Identifier:  
Sr. No:  17 Study Name:   The MAGICAL RCT (US FDA) Type of Study:   Target Patients:  120 Country:   Clinical Trials Identifier:  
Sr. No:  18 Study Name:   Hybrid Bifurcation PCI Type of Study:   Target Patients:  500 Country:   Clinical Trials Identifier:  
“Confidence through evidence”
Get in Touch